Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

2965

Actual shortage: 237 (8%)
Anticipated shortage: 27 (1%)
Avoided shortage: 9 (0%)
Resolved: 2692 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

25 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TRI-CIRA LO 28 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2018-12-27 2019-01-23 70526
TRI-CIRA LO 28 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-03-05 2019-05-21 77902
TRI-CIRA LO 28 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-03-13 2019-05-21 78558
TRI-CIRA LO 21 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-04-10 2019-08-26 80931
TRI-CIRA LO 28 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-08-07 2019-08-26 91109
TRI-CIRA LO 28 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG TABLET Resolved 2019-11-13 2019-11-18 98575
TRI-CIRA LO 21 0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG TABLET Resolved 2022-02-22 2022-03-07 155371
TRI-CIRA LO 21 0.025MG 0.25MG 0.025MG 0.215MG 0.025MG 0.18MG TABLET Resolved 2022-10-28 2023-04-14 172942
APO-CLONIDINE 0.025MG TABLET Actual shortage 2017-08-14 2017-10-05 19136
MYA 0.02MG 3.00MG TABLET Resolved 2023-05-26 2023-06-02 193206
MYA 0.02MG 3.00MG TABLET Resolved 2023-09-22 2023-10-06 204996
MYA 0.02MG 3.00MG TABLET Resolved 2023-12-15 2023-12-22 213568
MYA 0.02MG 3.00MG TABLET Resolved 2024-03-08 2024-03-15 221690
MIRVALA 28 0.0300MG 0.1500MG TABLET Resolved 2022-01-14 2022-01-18 152779
MIRVALA 21 0.0300MG 0.1500MG TABLET Resolved 2022-10-21 2022-11-07 172355
TRI-CIRA 21 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG TABLET Resolved 2022-12-02 2023-03-16 176945
TRI-CIRA 28 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG TABLET Resolved 2023-03-23 2023-08-12 187715
TRI-CIRA 21 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG TABLET Resolved 2023-04-06 2023-08-12 188979
TRI-CIRA 21 0.035MG 0.25MG 0.035MG 0.215MG 0.035MG 0.18MG TABLET Resolved 2024-01-05 2024-02-02 215236
ZAMINE 21 0.03MG 3MG TABLET Resolved 2023-06-16 2023-07-27 195081

Showing 21 to 40 of 2965

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DICLO SR 75MG TABLET (EXTENDED-RELEASE) Discontinued 2017-03-31 2017-03-31 4915
APO-IRBESARTAN 75MG TABLET Discontinued 2019-01-04 2019-01-04 71231
APO-DIPYRIDAMOLE 75MG TABLET Discontinued 2019-12-20 2019-12-21 101880
APO-FUROSEMIDE 80MG TABLET Discontinued 2017-03-30 2018-02-05 4719
APO-SOTALOL 80MG TABLET Discontinued 2017-03-31 2018-12-07 4936
APO-TELMISARTAN 80MG TABLET Discontinued 2018-02-23 2018-09-15 40817
APO-TELMISARTAN 80MG TABLET Discontinued 2018-02-23 2018-09-15 40820
APO-ATORVASTATIN 80MG TABLET Discontinued 2018-09-07 2018-12-29 60285
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
APO-ASA LD 81MG TABLET (DELAYED-RELEASE) Discontinued 2018-09-07 2018-09-15 60252
COATED DAILY LOW DOSE ASA 81 MG 81MG TABLET (DELAYED-RELEASE) Discontinued 2019-01-03 2019-01-04 71083
APO-METFORMIN 850MG TABLET Discontinued 2018-02-23 2019-06-12 40778
APO-METFORMIN 850MG TABLET Discontinued 2018-02-23 2018-09-15 40796
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60322
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60325
APO-HYDROMORPHONE CR 9MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110977

Showing 341 to 356 of 356